Neurology Diagnostics Devices Market

Neurology Diagnostics Devices Market Analysis By Product (Electroencephalogram, fMRI Systems, Optical Topography Systems, CT Scanners, Magnetoencephalography, Cerebral Oximetry Devices & Biomarker Tools) By Application & Region – Insights 2022 to 2032

Analysis of Neurology Diagnostics Devices market covering 30 + countries including analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more

Neurology Diagnostics Devices Market Outlook (2022-2032)

At the end of 2021, the global neurology diagnostics devices market was valued at US$ 8.24 billion and is anticipated to reach US$ 21.1 billion by 2032, expanding at a high CAGR of 8.9% over the 2022-2032 time frame.

As per a detailed industry analysis by Fact.MR, a market research and competitive intelligence provider, CT Scanners dominated the global market in 2021 accounting for 37.3% market share.

Sales of neurology diagnostics devices accounted for around 25% share of the global diagnostic imaging market in 2021.

Report Attribute

Details

Neurology Diagnostics Devices Market Size (2021)

US$ 8.24 Billion

Estimated Market Value (2022)

US$ 8.96 Billion

Forecasted Market Value (2032)

US$ 21.1 Billion

Global Market Growth Rate (2022-2032)

8.9% CAGR

East Asia Market Share (2021)

18.5%

East Asia Market Growth Rate (2022-2032)

10.6% CAGR

China Market Growth Rate (2022-2032)

10.2% CAGR

Market Share of Top 5 Countries

66%

Key Market Players

  • Quanterix, Cadwell Laboratories Inc.
  • Hitachi Medical Systems
  • Canon Medical Systems Corporation
  • Compumedics Limited
  • Koninklijke Philips N.V.
  • Medtronic plc., Siemens AG
  • Nonin Medical, Inc.
  • Nihon Kohden Corporation
  • Masimo
  • Natus Medical Incorporated
  • General Electric Company
  • Elekta AB
  • Neurosoft, Inc.
  • EB Neuro S.p.A.
  • Ricoh USA Inc.

Know thy Competitors

Competitive landscape highlights only certain players
Complete list available upon request

Demand Analysis of Neurology Diagnostics Devices (2012-2021) Vs. Market Outlook (2022-2032)

The global neurology diagnostics devices market expanded at a CAGR of 8% over the last nine years (2012-2021).

Sales of neurology diagnostics devices have been positively influenced by the rising prevalence of neurological disorders and increased focus on early diagnosis with the usage of reliable and safe devices for neurological treatment.

The focus of neurology is to diagnose and treat a wide range of brain and neurological disorders.

According to the most recent WHO survey (2021), neurological disorders such as stroke, Alzheimer's disease, epilepsy, and others account for more than 12% of all fatalities worldwide. It is also expected that by 2030, the number of years of life lost to neurological disorders will increase rapidly, from 95 million in 2015 to 103 million.

Additionally, it is anticipated that the global cost of neurological disorders alone was US$ 2.5 trillion in 2010, which will rise to US$ 6 trillion by 2030. The prevalence of neurological illnesses has significantly increased during the previous 25 years.

As such, Fact.MR expects the global neurology diagnostics devices market to be a fast-growing industry, with sales expected to surge at 8.9% CAGR over the forecast period (2022-2032).

What’s Mainly Driving Demand for Neurological Diagnostic Devices?

“Increasing Public Awareness Programs across Regions”

Patient care is the subject of numerous awareness campaigns, which is a key element in market growth. Globally, governments are putting more effort into promoting early detection, awareness, and recognition of the signs of neurological illnesses.

  • The World Federation of Neurology (WFN) is taking the lead in supporting brain health awareness with the introduction of its Brain Health Initiative (BHI). This program is focused on providing in-depth knowledge on several issues, such as the significance of brain health and the consequences of brain dysfunction.
  • In the U.S., the American Association of Neurological Surgeons (AANS), the Congress of Neurological Surgeons (CNS), and ten other national surgical associations jointly established a campaign to safeguard patients' access to care, in June 2020.

As a result, it is anticipated that increasing awareness will drive the demand for early neurology diagnosis, which will propel the market for neurology diagnostics devices in the years to come.

More Insights, Lesser Cost (-50% off)

Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR

What are the Opportunities for Key Suppliers of Neurology Diagnostics Devices?

“Collaborative Neuroscience Projects”

Besides having a substantial impact on medical science, the industrial economy, society, and other academic subjects, a new era of global neuroscience collaborations is establishing momentum.

  • For instance, the American government has proposed a national brain science project and started the Brain Research through the Advancing Innovative Neurotechnologies (BRAIN) initiative. The International Brain Research Organization, along with many other national projects from Korea, China, Canada, and Australia joined this initiative shortly after it was launched as a complement to the Human Brain Project in the European Union.

What’s Restraining Neurology Diagnostics Devices Market Growth?

“Product Recalls Hurting Market Progress”

Patients and personnel utilizing neurology diagnostics devices could be at risk of health problems as a consequence of ongoing quality issues with medical devices and related recalls. The expense of replacing and fixing defective devices or compensating injured customers is borne by the organization or the manufacturer, which may affect its financial investments. Recalls tend to damage a company's reputation and result in losses of several billions of dollars.

  • The FDA ordered Siemens Medical Systems Inc. to recall its SIEMENS SOMATOM, which uses the syngo CT VA30A SP4 software, in March 2022.

Software faults in models can lead to erratic problems that stop scanning processes, generate unexpected user warnings, and create artifacts in photos. Workflows for interventions might occasionally experience software problems.

Neurology diagnostics devices market na forecast by Fact.MR

Country-wise Insights

What is the U.S. Market Stance for Neurology Diagnostics Devices?

“Presence of Leading Players & High Regulatory Approvals”

The U.S. accounted for around 32 % share of the global neurology diagnostics devices market in 2021 owing to the presence of leading players such as General Electric, Canon Medical Systems Corporation, Siemens Medical Solutions USA, Inc., Masimo, and many others within the neurology space.

Additionally, the United States has highly-developed technological infrastructure that has helped it become a pioneer in technology and inspired many businesses to enter the market, thus aiding overall market expansion.

  • For instance, Masimo's O3 regional oximetry device was approved by FDA in September 2020. The device monitors somatic tissue oxygenation saturation as well as relative changes in haemoglobin, oxyhemoglobin, and deoxyhemoglobin in adult brains. This marks an important step in assisting clinicians and researchers in further increasing their understanding of how the body utilises oxygen and in identifying organ hypoxemia.

Why is the U.K. a Lucrative Market for Neurology Diagnostics Device Manufacturers?

“Growing Prevalence of Neurological Disorders in the Country”

The U.K. accounted for 5.6% share of the global neurology diagnostics devices market in 2021.

The effects of neurological diseases are widespread.

  • According to the Neurological Alliance Neuro Numbers 2019, there are reportedly 14.7 million cases of neurological disorders, which equates to one in every six citizens in the U.K. However, the annual spending on neurological diseases by NHS was reported to be around US$ 5.4 billion.

Rising disease prevalence will propel the country as a lucrative market for neurology diagnostics system manufacturers.

Which Factors are Fueling Demand for Neurology Diagnostics Devices in China?

“Growing Innovations Speeding Up Market Expansion”

China accounted for 14% of the global neurology diagnostics devices market share at the end of 2021.

  • According to the "Made in China 2025" plan, the Chinese government wants the manufacturing of biomedical and luxury medical devices to increase rapidly.

Chinese domestic manufacturers are focusing on expanding the national economy by offering hospitals in the country less expensive local alternatives to imported medical goods.

A majority of domestic Chinese medical equipment makers' offerings have always been inexpensive and low-tech. The approach focuses on the creation of high-performance gadgets such as telemedicine equipment, wearable tech, entirely biodegradable cardiovascular stents, robotic surgery tools, and diagnostic imaging equipment.

The high-end medical devices market in China will continue to expand as local Chinese companies develop their technological skills, thus propelling the neurology diagnostics devices market in the country.

Neurology diagnostics devices market region forecast by Fact.MR

Category-wise Insights

Why is Demand for CT Scanners Gaining High Traction?

“Growing Advancements in Imaging Technology”

The CT scanners segment held the highest market share of 37.3% in 2021. The segment is expected to expand at 8.3% CAGR throughout the forecast period. This traction is being influenced by increasing advancements and the installation of CT scanners.

Recent improvements in CT scanning technology have reduced the hazardous radiation that patients are exposed to, along with allowing faster scan times and enhanced image quality. These factors have driven up the popularity of CT scanners in the market.

Which Application of Neurology Diagnostics Devices Brings in Higher Revenue?

“Rising Mental Health Issues Globally”

The mental health segment held 22.7% share of the global market in 2021.

A significant portion of the population is becoming more vulnerable to several mental health problems due to changing lifestyles, as well as a growing number of people falling under the geriatric age group suffering from several disorders, including multiple sclerosis, Parkinson's disease, brain tumours, epilepsy, dementia, and stroke.

Don't Need a Global Report?

save 40%! on Country & Region specific reports

Competitive Landscape

Leading industry players in the field of neurology are currently focusing on expanding their operations into several nations across the globe. As part of their plan to hold onto their position in the market for neurology diagnostics devices globally, market players are also concentrating on innovation by developing and launching new products.

Collaborations and partnerships are major promotional strategies carried out by various key players.

  • In January 2022, the Tianjin Normal University (TJNU) was awarded Compumedics Limited's first MEG contract in Asia. Over time, the installation of the new MEG system will build a strong centre of expertise for Compumedics in the significant and quickly expanding Chinese neurosciences industry.
  • The National Cancer Center Japan Exploratory Oncology Research & Clinical Trial Center (NCC-EPOC), EAST Hospital, and Canon Medical Systems Corporation have partnered to perform research using PCCT, commencing in August 2021. (photon counting computed tomography).

Similarly, recent developments related to companies manufacturing neurology diagnostics devices have been tracked by the team at Fact.MR, which are available in the full report.

Key Segments in Neurology Diagnostics Devices Industry Research

  • By Product :

    • Electroencephalogram (EEG)
    • fMRI Systems
    • Optical Topography Systems (fNIRs)
    • CT Scanners
    • Magnetoencephalography (MEG)
    • Cerebral Oximetry Devices
    • Neuro-diagnostics Biomarker Tools
  • By Application :

    • Cognitive Diagnosis
    • Attention-Deficit/Hyperactivity Disorder (ADHD)
    • Mental Health
    • Stroke
    • Concussion
    • Dementia
    • PTSD
    • Other Neurological Diseases
  • By End User :

    • Neurofeedback Clinics
    • Neurology Clinics
    • Hospitals
    • Neurorehabilitation Centers
    • Academic and Research Institutes
  • By Region :

    • North America
    • Latin America
    • Europe
    • East Asia
    • South Asia
    • Oceania
    • Middle East and Africa (MEA)

Table of Content

1. Executive Summary

    1.1. Market Outlook

    1.2. Demand Side Trends

    1.3. Supply-Side Trends

    1.4. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

    2.3. Inclusions & Exclusions

3. Key Market Trends

    3.1. Key Trends Impacting the Market

    3.2. Innovation / Development Trends

4. Key Success Factors

    4.1. Product Adoption Analysis

    4.2. Product Features/ USPs Analysis

    4.3. Regulatory Scenario

    4.4. Reimbursement Scenario

    4.5. PESTLE Analysis

    4.6. Porter’s Analysis

    4.7. Value Chain Analysis

5. Market Background

    5.1. Macro-Economic Factors

        5.1.1. Global GDP Growth Outlook

        5.1.2. Global Healthcare Expenditure Market Outlook

        5.1.3. Diagnostic Imaging Market Outlook

    5.2. Forecast Factors - Relevance & Impact

        5.2.1. Rising focus on Research and Development

        5.2.2. Top Companies Historical Growth

        5.2.3. Product Adoption Rate and Demand

        5.2.4. Increasing burden of mental illnesses

        5.2.5. Availability of various Product

        5.2.6. COVID-19 impact

        5.2.7. Increasing Demand of Treatment for Neurological Diseases

        5.2.8. Increasing Market Consolidation Activities

    5.3. Market Dynamics

        5.3.1. Drivers

        5.3.2. Restraints

        5.3.3. Opportunity Analysis

6. COVID-19 Crisis Analysis

    6.1. 2021 Market Scenario

    6.2. COVID-19 Impact Analysis

        6.2.1. By Country

        6.2.2. By Product

        6.2.3. By Application

        6.2.4. By End User

7. Neurology Diagnostics Devices Market Demand (in Volume in Units) Analysis 2012-2021 and Forecast, 2022–2032

    7.1. Historical Market Value (US$ Mn) Analysis, 2012-2021

    7.2. Current and Future Market Value (US$ Mn) Projections, 2022–2032

        7.2.1. Y-o-Y Growth Trend Analysis

8. Global Neurology Diagnostics Devices Market - Pricing Analysis

    8.1. Regional Pricing Analysis By Product

    8.2. Average Pricing Analysis Benchmark

    8.3. Pricing Assumptions

9. Global Neurology Diagnostics Devices Market Demand (in Value or Size in US$ Mn) Analysis 2012-2021 and Forecast, 2022–2032

    9.1. Historical Market Value (US$ Mn) Analysis, 2012-2021

    9.2. Current and Future Market Value (US$ Mn) Projections, 2022–2032

        9.2.1. Y-o-Y Growth Trend Analysis

        9.2.2. Absolute $ Opportunity Analysis

10. Global Neurology Diagnostics Devices Market Analysis 2012-2021 and Forecast 2022–2032, by Product

    10.1. Introduction / Key Findings

    10.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Product, 2012-2021

    10.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast By Product, 2022–2032

        10.3.1. Electroencephalogram (EEG)

        10.3.2. fMRI Systems

        10.3.3. Optical Topography Systems (fNIRs)

        10.3.4. CT Scanners

        10.3.5. Magnetoencephalography (MEG)

        10.3.6. Cerebral Oximetry Devices

        10.3.7. Neuro-diagnostics Biomarker Tools

    10.4. Market Attractiveness Analysis By Product

11. Global Neurology Diagnostics Devices Market Analysis 2012-2021 and Forecast 2022–2032, by Application

    11.1. Introduction / Key Findings

    11.2. Historical Market Size (US$ Mn) Analysis By Application, 2012-2021

    11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Application, 2022–2032

        11.3.1. Cognitive Diagnosis

        11.3.2. Attention-deficit/hyperactivity disorder (ADHD)

        11.3.3. Mental Health

        11.3.4. Stroke

        11.3.5. Concussion

        11.3.6. Dementia

        11.3.7. PTSD

        11.3.8. Others Neurological Diseases

    11.4. Market Attractiveness Analysis By Application

12. Global Neurology Diagnostics Devices Market Analysis 2012-2021 and Forecast 2022–2032, by End User

    12.1. Introduction / Key Findings

    12.2. Historical Market Size (US$ Mn) Analysis By End User, 2012-2021

    12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2022–2032

        12.3.1. Neurofeedback Clinics

        12.3.2. Neurology Clinics

        12.3.3. Hospitals

        12.3.4. Neurorehabilitation Centers

        12.3.5. Academic and Research Institutes

    12.4. Market Attractiveness Analysis By End User

13. Global Neurology Diagnostics Devices Market Analysis 2012-2021 and Forecast 2022–2032, by Region

    13.1. Introduction

    13.2. Historical Market Size (US$ Mn) and Volume (Units)Analysis, By Region, 2012-2021

    13.3. Current and Future Market Size (US$ Mn) and Volume (Units)Analysis By Region, 2022–2032

        13.3.1. North America

        13.3.2. Latin America

        13.3.3. Europe

        13.3.4. East Asia

        13.3.5. South Asia

        13.3.6. Oceania

        13.3.7. Middle East and Africa

    13.4. Market Attractiveness Analysis By Region

14. North America Neurology Diagnostics Devices Market Analysis 2012-2021 and Forecast 2022–2032

    14.1. Introduction

    14.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market Taxonomy, 2012-2021

    14.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis By Market Taxonomy, 2022–2032

        14.3.1. By Country

            14.3.1.1. U.S.

            14.3.1.2. Canada

        14.3.2. By Product

        14.3.3. By Application

        14.3.4. By End User

    14.4. Market Attractiveness Analysis

        14.4.1. By Country

        14.4.2. By Product

        14.4.3. By Application

        14.4.4. By End User

    14.5. Key Market Participants - Intensity Mapping

    14.6. Drivers and Restraints - Impact Analysis

    14.7. Country Level Analysis & Forecast

        14.7.1. U.S. Neurology Diagnostics Devices Market

            14.7.1.1. Introduction

            14.7.1.2. Market Analysis and Forecast by Market Taxonomy

                14.7.1.2.1. By Product

                14.7.1.2.2. By Application

                14.7.1.2.3. By End User

        14.7.2. Canada Neurology Diagnostics Devices Market

            14.7.2.1. Introduction

            14.7.2.2. Market Analysis and Forecast by Market Taxonomy

                14.7.2.2.1. By Product

                14.7.2.2.2. By Application

                14.7.2.2.3. By End User

15. Latin America Neurology Diagnostics Devices Market Analysis 2014–2021 and Forecast 2022–2032

    15.1. Introduction

    15.2. Historical Market Size (US$ Mn) a and Volume (Units) Analysis By Market Taxonomy, 2014–2021

    15.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis, By Market Taxonomy, 2022–2032

        15.3.1. By Country

            15.3.1.1. Mexico

            15.3.1.2. Brazil

            15.3.1.3. Argentina

            15.3.1.4. Rest of Latin America

        15.3.2. By Product

        15.3.3. By Application

        15.3.4. By End User

    15.4. Market Attractiveness Analysis

        15.4.1. By Country

        15.4.2. By Product

        15.4.3. By Application

        15.4.4. By End User

    15.5. Key Market Participants - Intensity Mapping

    15.6. Drivers and Restraints - Impact Analysis

    15.7. Country Level Analysis & Forecast

        15.7.1. Mexico Neurology Diagnostics Devices Market Analysis

            15.7.1.1. Introduction

            15.7.1.2. Market Analysis and Forecast by Market Taxonomy

                15.7.1.2.1. By Product

                15.7.1.2.2. By Application

                15.7.1.2.3. By End User

        15.7.2. Brazil Neurology Diagnostics Devices Market Analysis

            15.7.2.1. Introduction

            15.7.2.2. Market Analysis and Forecast by Market Taxonomy

                15.7.2.2.1. By Product

                15.7.2.2.2. By Application

                15.7.2.2.3. By End User

        15.7.3. Argentina Neurology Diagnostics Devices Market Analysis

            15.7.3.1. Introduction

            15.7.3.2. Market Analysis and Forecast by Market Taxonomy

                15.7.3.2.1. By Product

                15.7.3.2.2. By Application

                15.7.3.2.3. By End User

16. Europe Neurology Diagnostics Devices Market Analysis 2012-2021 and Forecast 2022–2032

    16.1. Introduction

    16.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market Taxonomy, 2012-2021

    16.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis By Market Taxonomy, 2022–2032

        16.3.1. By Country

            16.3.1.1. Germany

            16.3.1.2. Italy

            16.3.1.3. France

            16.3.1.4. U.K.

            16.3.1.5. Spain

            16.3.1.6. BENELUX

            16.3.1.7. Nordic Countries

            16.3.1.8. Russia

            16.3.1.9. Rest of Europe

        16.3.2. By Product

        16.3.3. By Application

        16.3.4. By End User

    16.4. Market Attractiveness Analysis

        16.4.1. By Country

        16.4.2. By Product

        16.4.3. By Application

        16.4.4. By End User

    16.5. Key Market Participants - Intensity Mapping

    16.6. Drivers and Restraints - Impact Analysis

    16.7. Country Level Analysis & Forecast

        16.7.1. Germany Neurology Diagnostics Devices Market

            16.7.1.1. Introduction

            16.7.1.2. Market Analysis and Forecast by Market Taxonomy

                16.7.1.2.1. By Product

                16.7.1.2.2. By Application

                16.7.1.2.3. By End User

        16.7.2. France Neurology Diagnostics Devices Market

            16.7.2.1. Introduction

            16.7.2.2. Market Analysis and Forecast by Market Taxonomy

                16.7.2.2.1. By Product

                16.7.2.2.2. By Application

                16.7.2.2.3. By End User

        16.7.3. Italy Neurology Diagnostics Devices Market

            16.7.3.1. Introduction

            16.7.3.2. Market Analysis and Forecast by Market Taxonomy

                16.7.3.2.1. By Product

                16.7.3.2.2. By Application

                16.7.3.2.3. By End User

        16.7.4. Spain Neurology Diagnostics Devices Market

            16.7.4.1. Introduction

            16.7.4.2. Market Analysis and Forecast by Market Taxonomy

                16.7.4.2.1. By Product

                16.7.4.2.2. By Application

                16.7.4.2.3. By End User

        16.7.5. U.K. Neurology Diagnostics Devices Market

            16.7.5.1. Introduction

            16.7.5.2. Market Analysis and Forecast by Market Taxonomy

                16.7.5.2.1. By Product

                16.7.5.2.2. By Application

                16.7.5.2.3. By End User

        16.7.6. BENELUX Union Neurology Diagnostics Devices Market

            16.7.6.1. Introduction

            16.7.6.2. Market Analysis and Forecast by Market Taxonomy

                16.7.6.2.1. By Product

                16.7.6.2.2. By Application

                16.7.6.2.3. By End User

        16.7.7. Nordic Countries Neurology Diagnostics Devices Market

            16.7.7.1. Introduction

            16.7.7.2. Market Analysis and Forecast by Market Taxonomy

                16.7.7.2.1. By Product

                16.7.7.2.2. By Application

                16.7.7.2.3. By End User

        16.7.8. Russia Neurology Diagnostics Devices Market

            16.7.8.1. Introduction

            16.7.8.2. Market Analysis and Forecast by Market Taxonomy

                16.7.8.2.1. By Product

                16.7.8.2.2. By Application

                16.7.8.2.3. By End User

17. South Asia Neurology Diagnostics Devices Market Analysis 2014–2021 and Forecast 2022–2032

    17.1. Introduction

    17.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market Taxonomy, 2014–2021

    17.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis, By Market Taxonomy, 2022–2032

        17.3.1. By Country

            17.3.1.1. India

            17.3.1.2. Indonesia

            17.3.1.3. Malaysia

            17.3.1.4. Thailand

            17.3.1.5. Rest of South Asia

        17.3.2. By Product

        17.3.3. By Application

        17.3.4. By End User

    17.4. Market Attractiveness Analysis

        17.4.1. By Country

        17.4.2. By Product

        17.4.3. By Application

        17.4.4. By End User

    17.5. Key Market Participants - Intensity Mapping

    17.6. Drivers and Restraints - Impact Analysis

    17.7. Country Level Analysis & Forecast

        17.7.1. India Neurology Diagnostics Devices Market Analysis

            17.7.1.1. Introduction

            17.7.1.2. Market Analysis and Forecast by Market Taxonomy

                17.7.1.2.1. By Product

                17.7.1.2.2. By Application

                17.7.1.2.3. By End User

        17.7.2. Indonesia Neurology Diagnostics Devices Market Analysis

            17.7.2.1. Introduction

            17.7.2.2. Market Analysis and Forecast by Market Taxonomy

                17.7.2.2.1. By Product

                17.7.2.2.2. By Application

                17.7.2.2.3. By End User

        17.7.3. Malaysia Neurology Diagnostics Devices Market Analysis

            17.7.3.1. Introduction

            17.7.3.2. Market Analysis and Forecast by Market Taxonomy

                17.7.3.2.1. By Product

                17.7.3.2.2. By Application

                17.7.3.2.3. By End User

        17.7.4. Thailand Neurology Diagnostics Devices Market Analysis

            17.7.4.1. Introduction

            17.7.4.2. Market Analysis and Forecast by Market Taxonomy

                17.7.4.2.1. By Product

                17.7.4.2.2. By Application

                17.7.4.2.3. By End User

18. East Asia Neurology Diagnostics Devices Market Analysis 2014–2021 and Forecast 2022–2032

    18.1. Introduction

    18.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market Taxonomy, 2014–2021

    18.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis, By Market Taxonomy, 2022–2032

        18.3.1. By Country

            18.3.1.1. China

            18.3.1.2. Japan

            18.3.1.3. South Korea

        18.3.2. By Product

        18.3.3. By Application

        18.3.4. By End User

    18.4. Market Attractiveness Analysis

        18.4.1. By Country

        18.4.2. By Product

        18.4.3. By Application

        18.4.4. By End User

    18.5. Key Market Participants - Intensity Mapping

    18.6. Drivers and Restraints - Impact Analysis

    18.7. Country Level Analysis & Forecast

        18.7.1. China Neurology Diagnostics Devices Market Analysis

            18.7.1.1. Introduction

            18.7.1.2. Market Analysis and Forecast by Market Taxonomy

                18.7.1.2.1. By Product

                18.7.1.2.2. By Application

                18.7.1.2.3. By End User

        18.7.2. Japan Neurology Diagnostics Devices Market Analysis

            18.7.2.1. Introduction

            18.7.2.2. Market Analysis and Forecast by Market Taxonomy

                18.7.2.2.1. By Product

                18.7.2.2.2. By Application

                18.7.2.2.3. By End User

        18.7.3. South Korea Neurology Diagnostics Devices Market Analysis

            18.7.3.1. Introduction

            18.7.3.2. Market Analysis and Forecast by Market Taxonomy

                18.7.3.2.1. By Product

                18.7.3.2.2. By Application

                18.7.3.2.3. By End User

19. Oceania Neurology Diagnostics Devices Market 2017-2021 and Forecast 2022-2032

    19.1. Introduction

    19.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market Taxonomy, 2014–2021

    19.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis, By Market Taxonomy, 2022–2032

        19.3.1. By Country

            19.3.1.1. Australia

            19.3.1.2. New Zealand

        19.3.2. By Product

        19.3.3. By Application

        19.3.4. By End User

    19.4. Market Attractiveness Analysis

        19.4.1. By Country

        19.4.2. By Product

        19.4.3. By Application

        19.4.4. By End User

    19.5. Key Market Participants - Intensity Mapping

    19.6. Drivers and Restraints - Impact Analysis

    19.7. Country Level Analysis & Forecast

        19.7.1. Australia Neurology Diagnostics Devices Market Analysis

            19.7.1.1. Introduction

            19.7.1.2. Market Analysis and Forecast by Market Taxonomy

                19.7.1.2.1. By Product

                19.7.1.2.2. By Application

                19.7.1.2.3. By End User

        19.7.2. New Zealand Neurology Diagnostics Devices Market Analysis

            19.7.2.1. Introduction

            19.7.2.2. Market Analysis and Forecast by Market Taxonomy

                19.7.2.2.1. By Product

                19.7.2.2.2. By Application

                19.7.2.2.3. By End User

20. Middle East and Africa (MEA) Neurology Diagnostics Devices Market Analysis 2014–2021 and Forecast 2022–2032

    20.1. Introduction

    20.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market Taxonomy, 2014–2021

    20.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis, By Market Taxonomy, 2022–2032

        20.3.1. By Country

            20.3.1.1. GCC Countries

            20.3.1.2. South Africa

            20.3.1.3. North Africa

            20.3.1.4. Turkey

            20.3.1.5. Rest of Middle East and Africa

        20.3.2. By Product

        20.3.3. By Application

        20.3.4. By End User

    20.4. Market Attractiveness Analysis

        20.4.1. By Country

        20.4.2. By Product

        20.4.3. By Application

        20.4.4. By End User

    20.5. Key Market Participants - Intensity Mapping

    20.6. Drivers and Restraints - Impact Analysis

    20.7. Country Level Analysis & Forecast

        20.7.1. GCC Countries Neurology Diagnostics Devices Market Analysis

            20.7.1.1. Introduction

            20.7.1.2. Market Analysis and Forecast by Market Taxonomy

                20.7.1.2.1. By Product

                20.7.1.2.2. By Application

                20.7.1.2.3. By End User

        20.7.2. South Africa Neurology Diagnostics Devices Market Analysis

            20.7.2.1. Introduction

            20.7.2.2. Market Analysis and Forecast by Market Taxonomy

                20.7.2.2.1. By Product

                20.7.2.2.2. By Application

                20.7.2.2.3. By End User

        20.7.3. North Africa Neurology Diagnostics Devices Market Analysis

            20.7.3.1. Introduction

            20.7.3.2. Market Analysis and Forecast by Market Taxonomy

                20.7.3.2.1. By Product

                20.7.3.2.2. By Application

                20.7.3.2.3. By End User

        20.7.4. Turkey Neurology Diagnostics Devices Market Analysis

            20.7.4.1. Introduction

            20.7.4.2. Market Analysis and Forecast by Market Taxonomy

                20.7.4.2.1. By Product

                20.7.4.2.2. By Application

                20.7.4.2.3. By End User

21. Market Structure Analysis

    21.1. Market Analysis by Tier of Companies

    21.2. Market Share Analysis of Top Players

22. Competition Analysis

    22.1. Competition Dashboard

    22.2. Competition Benchmarking

    22.3. Competition Deep Dive

        22.3.1. Quanterix

            22.3.1.1. Overview

            22.3.1.2. Product Portfolio

            22.3.1.3. Key Financials

            22.3.1.4. Sales Footprint

            22.3.1.5. SWOT Analysis

            22.3.1.6. Key Developments

            22.3.1.7. Strategy Overview

                22.3.1.7.1. Channel Strategy

                22.3.1.7.2. Marketing Strategy

                22.3.1.7.3. Product Strategy

        22.3.2. Cadwell Laboratories Inc.

            22.3.2.1. Overview

            22.3.2.2. Product Portfolio

            22.3.2.3. Key Financials

            22.3.2.4. Sales Footprint

            22.3.2.5. SWOT Analysis

            22.3.2.6. Key Developments

            22.3.2.7. Strategy Overview

                22.3.2.7.1. Channel Strategy

                22.3.2.7.2. Marketing Strategy

                22.3.2.7.3. Product Strategy

        22.3.3. Hitachi Medical Systems

            22.3.3.1. Overview

            22.3.3.2. Product Portfolio

            22.3.3.3. Key Financials

            22.3.3.4. Sales Footprint

            22.3.3.5. SWOT Analysis

            22.3.3.6. Key Developments

            22.3.3.7. Strategy Overview

                22.3.3.7.1. Channel Strategy

                22.3.3.7.2. Marketing Strategy

                22.3.3.7.3. Product Strategy

        22.3.4. Canon Medical Systems Corporation

            22.3.4.1. Overview

            22.3.4.2. Product Portfolio

            22.3.4.3. Key Financials

            22.3.4.4. Sales Footprint

            22.3.4.5. SWOT Analysis

            22.3.4.6. Key Developments

            22.3.4.7. Strategy Overview

                22.3.4.7.1. Channel Strategy

                22.3.4.7.2. Marketing Strategy

                22.3.4.7.3. Product Strategy

        22.3.5. Compumedics Limited

            22.3.5.1. Overview

            22.3.5.2. Product Portfolio

            22.3.5.3. Key Financials

            22.3.5.4. Sales Footprint

            22.3.5.5. SWOT Analysis

            22.3.5.6. Key Developments

            22.3.5.7. Strategy Overview

                22.3.5.7.1. Channel Strategy

                22.3.5.7.2. Marketing Strategy

                22.3.5.7.3. Product Strategy

        22.3.6. Koninklijke Philips N.V.

            22.3.6.1. Overview

            22.3.6.2. Product Portfolio

            22.3.6.3. Key Financials

            22.3.6.4. Sales Footprint

            22.3.6.5. SWOT Analysis

            22.3.6.6. Key Developments

            22.3.6.7. Strategy Overview

                22.3.6.7.1. Channel Strategy

                22.3.6.7.2. Marketing Strategy

                22.3.6.7.3. Product Strategy

        22.3.7. Medtronic plc.

            22.3.7.1. Overview

            22.3.7.2. Product Portfolio

            22.3.7.3. Key Financials

            22.3.7.4. Sales Footprint

            22.3.7.5. SWOT Analysis

            22.3.7.6. Key Developments

            22.3.7.7. Strategy Overview

                22.3.7.7.1. Channel Strategy

                22.3.7.7.2. Marketing Strategy

                22.3.7.7.3. Product Strategy

        22.3.8. Siemens AG

            22.3.8.1. Overview

            22.3.8.2. Product Portfolio

            22.3.8.3. Key Financials

            22.3.8.4. Sales Footprint

            22.3.8.5. SWOT Analysis

            22.3.8.6. Key Developments

            22.3.8.7. Strategy Overview

                22.3.8.7.1. Channel Strategy

                22.3.8.7.2. Marketing Strategy

                22.3.8.7.3. Product Strategy

        22.3.9. Nonin Medical, Inc.

            22.3.9.1. Overview

            22.3.9.2. Product Portfolio

            22.3.9.3. Key Financials

            22.3.9.4. Sales Footprint

            22.3.9.5. SWOT Analysis

            22.3.9.6. Key Developments

            22.3.9.7. Strategy Overview

                22.3.9.7.1. Channel Strategy

                22.3.9.7.2. Marketing Strategy

                22.3.9.7.3. Product Strategy

        22.3.10. Nihon Kohden Corporation

            22.3.10.1. Overview

            22.3.10.2. Product Portfolio

            22.3.10.3. Key Financials

            22.3.10.4. Sales Footprint

            22.3.10.5. SWOT Analysis

            22.3.10.6. Key Developments

            22.3.10.7. Strategy Overview

                22.3.10.7.1. Channel Strategy

                22.3.10.7.2. Marketing Strategy

                22.3.10.7.3. Product Strategy

        22.3.11. Masimo

            22.3.11.1. Overview

            22.3.11.2. Product Portfolio

            22.3.11.3. Key Financials

            22.3.11.4. Sales Footprint

            22.3.11.5. SWOT Analysis

            22.3.11.6. Key Developments

            22.3.11.7. Strategy Overview

                22.3.11.7.1. Channel Strategy

                22.3.11.7.2. Marketing Strategy

                22.3.11.7.3. Product Strategy

        22.3.12. Natus Medical Incorporated

            22.3.12.1. Overview

            22.3.12.2. Product Portfolio

            22.3.12.3. Key Financials

            22.3.12.4. Sales Footprint

            22.3.12.5. SWOT Analysis

            22.3.12.6. Key Developments

            22.3.12.7. Strategy Overview

                22.3.12.7.1. Channel Strategy

                22.3.12.7.2. Marketing Strategy

                22.3.12.7.3. Product Strategy

        22.3.13. General Electric Company

            22.3.13.1. Overview

            22.3.13.2. Product Portfolio

            22.3.13.3. Key Financials

            22.3.13.4. Sales Footprint

            22.3.13.5. SWOT Analysis

            22.3.13.6. Key Developments

            22.3.13.7. Strategy Overview

                22.3.13.7.1. Channel Strategy

                22.3.13.7.2. Marketing Strategy

                22.3.13.7.3. Product Strategy

        22.3.14. Elekta AB

            22.3.14.1. Overview

            22.3.14.2. Product Portfolio

            22.3.14.3. Key Financials

            22.3.14.4. Sales Footprint

            22.3.14.5. SWOT Analysis

            22.3.14.6. Key Developments

            22.3.14.7. Strategy Overview

                22.3.14.7.1. Channel Strategy

                22.3.14.7.2. Marketing Strategy

                22.3.14.7.3. Product Strategy

        22.3.15. Neurosoft, Inc.

            22.3.15.1. Overview

            22.3.15.2. Product Portfolio

            22.3.15.3. Key Financials

            22.3.15.4. Sales Footprint

            22.3.15.5. SWOT Analysis

            22.3.15.6. Key Developments

            22.3.15.7. Strategy Overview

                22.3.15.7.1. Channel Strategy

                22.3.15.7.2. Marketing Strategy

                22.3.15.7.3. Product Strategy

        22.3.16. EB Neuro S.p.A.

            22.3.16.1. Overview

            22.3.16.2. Product Portfolio

            22.3.16.3. Key Financials

            22.3.16.4. Sales Footprint

            22.3.16.5. SWOT Analysis

            22.3.16.6. Key Developments

            22.3.16.7. Strategy Overview

                22.3.16.7.1. Channel Strategy

                22.3.16.7.2. Marketing Strategy

                22.3.16.7.3. Product Strategy

        22.3.17. Ricoh USA Inc.

            22.3.17.1. Overview

            22.3.17.2. Product Portfolio

            22.3.17.3. Key Financials

            22.3.17.4. Sales Footprint

            22.3.17.5. SWOT Analysis

            22.3.17.6. Key Developments

            22.3.17.7. Strategy Overview

                22.3.17.7.1. Channel Strategy

                22.3.17.7.2. Marketing Strategy

                22.3.17.7.3. Product Strategy

23. Assumptions and Acronyms Used

24. Research Methodology

Don't Need a Global Report?

save 40%! on Country & Region specific reports

List Of Table

Table 01: Global Neurology Diagnostics Devices Market Size (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, By Product

Table 02: Global Neurology Diagnostics Devices Market Volume (Units) Analysis 2012–2021 and Forecast 2022–2032, By Product

Table 03: Global Neurology Diagnostics Devices Market Size (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, By Application

Table 04: Global Neurology Diagnostics Devices Market Size (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, By End User

Table 05: Global Neurology Diagnostics Devices Market Size (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, By Region

Table 06: Global Neurology Diagnostics Devices Market Volume (Units) Analysis 2012–2021 and Forecast 2022–2032, By Region

Table 07: North America Neurology Diagnostics Devices Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, By Country

Table 08: North America Neurology Diagnostics Devices Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, By Product

Table 09: North America Neurology Diagnostics Devices Market Volume (Units) Analysis 2012–2021 and Forecast 2022–2032, By Product

Table 10: North America Neurology Diagnostics Devices Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, By Application

Table 11: North America Neurology Diagnostics Devices Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, By End User

Table 12: Latin America Neurology Diagnostics Devices Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, By Country

Table 13: Latin America Neurology Diagnostics Devices Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, By Product

Table 14: Latin America Neurology Diagnostics Devices Market Volume (Units) Analysis 2012–2021 and Forecast 2022–2032, By Product

Table 15: Latin America Neurology Diagnostics Devices Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, By Application

Table 16: Latin America Neurology Diagnostics Devices Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, By End User

Table 17: Europe Neurology Diagnostics Devices Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, By Country

Table 18: Europe Neurology Diagnostics Devices Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, By Product

Table 19: Europe Neurology Diagnostics Devices Market Volume (Units) Analysis 2012–2021 and Forecast 2022–2032, By Product

Table 20: Europe Neurology Diagnostics Devices Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, By Application

Table 21: Europe Neurology Diagnostics Devices Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, By End User

Table 22: South Asia Neurology Diagnostics Devices Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, By Country

Table 23: South Asia Neurology Diagnostics Devices Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, By Product

Table 24: South Asia Neurology Diagnostics Devices Market Volume (Units) Analysis 2012–2021 and Forecast 2022–2032, By Product

Table 25: South Asia Neurology Diagnostics Devices Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, By Application

Table 26: South Asia Neurology Diagnostics Devices Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, By End User

Table 27: East Asia Neurology Diagnostics Devices Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, By Country

Table 28: East Asia Neurology Diagnostics Devices Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, By Product

Table 29: East Asia Neurology Diagnostics Devices Market Volume (Units) Analysis 2012–2021 and Forecast 2022–2032, By Product

Table 30: East Asia Neurology Diagnostics Devices Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, By Application

Table 31: East Asia Neurology Diagnostics Devices Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, By End User

Table 32: Oceania Neurology Diagnostics Devices Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, By Country

Table 33: Oceania Neurology Diagnostics Devices Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, By Product

Table 34: Oceania Neurology Diagnostics Devices Market Volume (Units) Analysis 2012–2021 and Forecast 2022–2032, By Product

Table 35: Oceania Neurology Diagnostics Devices Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, By Application

Table 36: Oceania Neurology Diagnostics Devices Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, By End User

Table 37: Middle East and Africa Neurology Diagnostics Devices Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, By Country

Table 38: Middle East and Africa Neurology Diagnostics Devices Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, By Product

Table 39: Middle East and Africa Neurology Diagnostics Devices Market Volume (Units) Analysis 2012–2021 and Forecast 2022–2032, By Product

Table 40: Middle East and Africa Neurology Diagnostics Devices Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, By Application

Table 41: Middle East and Africa Neurology Diagnostics Devices Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, By End User

More Insights, Lesser Cost (-50% off)

Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR

List Of Figures

Figure 01: Global Neurology Diagnostics Devices Market Revenue Share by Product, 2021A & 2032F

Figure 02: Global Neurology Diagnostics Devices Market Revenue Share by Application, 2021A & 2032F

Figure 03: Global Neurology Diagnostics Devices Market Revenue Share by End User, 2021A & 2032F

Figure 04: Global Neurology Diagnostics Devices Market Revenue Share by Region, 2021A & 2032F

Figure 05: Global Neurology Diagnostics Devices Market Volume (Units) Analysis, 2012–2021

Figure 06: Global Neurology Diagnostics Devices Market Volume (Unit) & Y-o-Y Growth (%) Analysis, 2022–2032

Figure 07: Global Average Pricing Analysis Benchmark USD (Unit) (2021)

Figure 08: Global Neurology Diagnostics Devices, Pricing Analysis (US$) By Region, 2021

Figure 09: Global Neurology Diagnostics Devices, Pricing Analysis (US$) By Region, 2032

Figure 10: Global Neurology Diagnostics Devices Market Value Analysis, 2012–2021

Figure 11: Global Neurology Diagnostics Devices Market Forecast & Y-o-Y Growth, 2022–2032

Figure 12: Global Neurology Diagnostics Devices Market Absolute $ Opportunity, 2022 –2032

Figure 13: Global Neurology Diagnostics Devices Market Value Share (%) Analysis 2022 and 2032, By Product

Figure 14: Global Neurology Diagnostics Devices Market Y-o-Y Growth (%) Analysis 2021-2032, By Product

Figure 15: Global Neurology Diagnostics Devices Market Attractiveness Analysis 2022–2032, By Product

Figure 16: Global Neurology Diagnostics Devices Market Value Share (%) Analysis 2022 and 2032, By Application

Figure 17: Global Neurology Diagnostics Devices Market Y-o-Y Growth (%) Analysis 2021-2032, By Application

Figure 18: Global Neurology Diagnostics Devices Market Attractiveness Analysis 2022–2032, By Application

Figure 19: Global Neurology Diagnostics Devices Market Value Share (%) Analysis 2022 and 2032, By End User

Figure 20: Global Neurology Diagnostics Devices Market Y-o-Y Growth (%) Analysis 2021-2032, By End User

Figure 21: Global Neurology Diagnostics Devices Market Attractiveness Analysis 2022–2032, By End User

Figure 22: Global Neurology Diagnostics Devices Market Value Share (%) Analysis 2022 and 2032, By Region

Figure 23: Global Neurology Diagnostics Devices Market Y-o-Y Growth (%) Analysis 2021-2032, By Region

Figure 24: Global Neurology Diagnostics Devices Market Attractiveness Analysis 2022–2032, By Region

Figure 25: North America Neurology Diagnostics Devices Market Volume (Units) Analysis, 2022E & 2032F

Figure 26: North America Neurology Diagnostics Devices Market Volume (Units) Analysis, 2022E & 2032F

Figure 27: North America Neurology Diagnostics Devices Market Value Analysis, 2012–2021

Figure 28: North America Neurology Diagnostics Devices Market Forecast & Y-o-Y growth, 2022–2032

Figure 29: North America Neurology Diagnostics Devices Market Value Share By Product (2022E)

Figure 30: North America Neurology Diagnostics Devices Market Value Share By Application (2022E)

Figure 31: North America Neurology Diagnostics Devices Market Value Share By End User (2022E)

Figure 32: North America Neurology Diagnostics Devices Market Value Share By Country (2022E)

Figure 33: North America Neurology Diagnostics Devices Market Attractiveness Analysis, By Product

Figure 34: North America Neurology Diagnostics Devices Market Attractiveness Analysis, By Application

Figure 35: North America Neurology Diagnostics Devices Market Attractiveness Analysis, By End User

Figure 36: North America Neurology Diagnostics Devices Market Attractiveness Analysis, By Country

Figure 37: U.S. Neurology Diagnostics Devices Market Value Proportion Analysis, 2021

Figure 38: U.S. Neurology Diagnostics Devices Market Share Analysis (%) By Product, 2021 & 2032

Figure 39: U.S. Neurology Diagnostics Devices Market Share Analysis (%) By Application, 2021 & 2032

Figure 40: U.S. Neurology Diagnostics Devices Market Share Analysis (%) By End User, 2021 & 2032

Figure 41: Canada Neurology Diagnostics Devices Market Value Proportion Analysis, 2021

Figure 42: Canada Neurology Diagnostics Devices Market Share Analysis (%) By Product, 2021 & 2032

Figure 43: Canada Neurology Diagnostics Devices Market Share Analysis (%) By Application, 2021 & 2032

Figure 44: Canada Neurology Diagnostics Devices Market Share Analysis (%) By End User, 2021 & 2032

Figure 45: Latin America Neurology Diagnostics Devices Market Volume (Units) Analysis, 2022E & 2032F

Figure 46: Latin America Neurology Diagnostics Devices Market Volume (Units) Analysis, 2022E & 2032F

Figure 47: Latin America Neurology Diagnostics Devices Market Value Analysis, 2012–2021

Figure 48: Latin America Neurology Diagnostics Devices Market Forecast & Y-o-Y growth, 2022–2032

Figure 49: Latin America Neurology Diagnostics Devices Market Value Share By Product (2022E)

Figure 50: Latin America Neurology Diagnostics Devices Market Value Share By Application (2022E)

Figure 51: Latin America Neurology Diagnostics Devices Market Value Share By End User (2022E)

Figure 52: Latin America Neurology Diagnostics Devices Market Value Share By Country (2022E)

Figure 53: Latin America Neurology Diagnostics Devices Market Attractiveness Analysis, By Product

Figure 54: Latin America Neurology Diagnostics Devices Market Attractiveness Analysis, By Application

Figure 55: Latin America Neurology Diagnostics Devices Market Attractiveness Analysis, By End User

Figure 56: Latin America Neurology Diagnostics Devices Market Attractiveness Analysis, By Country

Figure 57: Brazil Market Value Proportion Analysis

Figure 58: Brazil Neurology Diagnostics Devices Market Share Analysis (%) By Product, 2021 & 2032

Figure 59: Brazil Neurology Diagnostics Devices Market Share Analysis (%) By Application, 2021 & 2032

Figure 60: Brazil Neurology Diagnostics Devices Market Share Analysis (%) By End User, 2021 & 2032

Figure 61: Mexico Market Value Proportion Analysis

Figure 62: Mexico Neurology Diagnostics Devices Market Share Analysis (%) By Product, 2021 & 2032

Figure 63: Mexico Neurology Diagnostics Devices Market Share Analysis (%) By Application, 2021 & 2032

Figure 64: Mexico Neurology Diagnostics Devices Market Share Analysis (%) By End User, 2021 & 2032

Figure 65: Argentina Market Value Proportion Analysis

Figure 66: Argentina Neurology Diagnostics Devices Market Share Analysis (%) By Product, 2021 & 2032

Figure 67: Argentina Neurology Diagnostics Devices Market Share Analysis (%) By Application, 2021 & 2032

Figure 68: Argentina Neurology Diagnostics Devices Market Share Analysis (%) By End User, 2021 & 2032

Figure 69: Europe Neurology Diagnostics Devices Market Volume (Units) Analysis, 2022E & 2032F

Figure 70: Europe Neurology Diagnostics Devices Market Volume (Units) Analysis, 2022E & 2032F

Figure 71: Europe Neurology Diagnostics Devices Market Value Analysis, 2012–2021

Figure 72: Europe Neurology Diagnostics Devices Market Forecast & Y-o-Y growth, 2022–2032

Figure 73: Europe Neurology Diagnostics Devices Market Value Share By Product (2022E)

Figure 74: Europe Neurology Diagnostics Devices Market Value Share By Application (2022E)

Figure 75: Europe Neurology Diagnostics Devices Market Value Share By End User (2022E)

Figure 76: Europe Neurology Diagnostics Devices Market Value Share By Country (2022E)

Figure 77: Europe Neurology Diagnostics Devices Market Attractiveness Analysis, By Product

Figure 78: Europe Neurology Diagnostics Devices Market Attractiveness Analysis, By Application

Figure 79: Europe Neurology Diagnostics Devices Market Attractiveness Analysis, By End User

Figure 80: Europe Neurology Diagnostics Devices Market Attractiveness Analysis, By Country

Figure 81: Germany Market Value Proportion Analysis

Figure 82: Germany Neurology Diagnostics Devices Market Share Analysis (%) By Product, 2021 & 2032

Figure 83: Germany Neurology Diagnostics Devices Market Share Analysis (%) By Application, 2021 & 2032

Figure 84: Germany Neurology Diagnostics Devices Market Share Analysis (%) By End User, 2021 & 2032

Figure 85: Italy Market Value Proportion Analysis

Figure 86: Italy Neurology Diagnostics Devices Market Share Analysis (%) By Product, 2021 & 2032

Figure 87: Italy Neurology Diagnostics Devices Market Share Analysis (%) By Application, 2021 & 2032

Figure 88: Italy Neurology Diagnostics Devices Market Share Analysis (%) By End User, 2021 & 2032

Figure 89: France Market Value Proportion Analysis

Figure 90: France Neurology Diagnostics Devices Market Share Analysis (%) By Product, 2021 & 2032

Figure 91: France Neurology Diagnostics Devices Market Share Analysis (%) By Application, 2021 & 2032

Figure 92: France Neurology Diagnostics Devices Market Share Analysis (%) By End User, 2021 & 2032

Figure 93: U.K. Market Value Proportion Analysis

Figure 94: U.K. Neurology Diagnostics Devices Market Share Analysis (%) By Product, 2021 & 2032

Figure 95: U.K. Neurology Diagnostics Devices Market Share Analysis (%) By Application, 2021 & 2032

Figure 96: U.K. Neurology Diagnostics Devices Market Share Analysis (%) By End User, 2021 & 2032

Figure 97: Spain Market Value Proportion Analysis

Figure 98: Spain Neurology Diagnostics Devices Market Share Analysis (%) By Product, 2021 & 2032

Figure 99: Spain Neurology Diagnostics Devices Market Share Analysis (%) By Application, 2021 & 2032

Figure 100: Spain Neurology Diagnostics Devices Market Share Analysis (%) By End User, 2021 & 2032

Figure 101: BENELUX Market Value Proportion Analysis

Figure 102: BENELUX Neurology Diagnostics Devices Market Share Analysis (%) By Product, 2021 & 2032

Figure 103: BENELUX Neurology Diagnostics Devices Market Share Analysis (%) By Application, 2021 & 2032

Figure 104: BENELUX Neurology Diagnostics Devices Market Share Analysis (%) By End User, 2021 & 2032

Figure 105: Russia Market Value Proportion Analysis

Figure 106: Russia Neurology Diagnostics Devices Market Share Analysis (%) By Product, 2021 & 2032

Figure 107: Russia Neurology Diagnostics Devices Market Share Analysis (%) By Application, 2021 & 2032

Figure 108: Russia Neurology Diagnostics Devices Market Share Analysis (%) By End User, 2021 & 2032

Figure 109: Nordic Countries Market Value Proportion Analysis

Figure 110: Nordic Countries Neurology Diagnostics Devices Market Share Analysis (%) By Product, 2021 & 2032

Figure 111: Nordic Countries Neurology Diagnostics Devices Market Share Analysis (%) By Application, 2021 & 2032

Figure 112: Nordic Countries Neurology Diagnostics Devices Market Share Analysis (%) By End User, 2021 & 2032

Figure 113: South Asia Neurology Diagnostics Devices Market Volume (Units) Analysis, 2022E & 2032F

Figure 114: South Asia Neurology Diagnostics Devices Market Volume (Units) Analysis, 2022E & 2032F

Figure 115: South Asia Neurology Diagnostics Devices Market Value Analysis, 2012–2021

Figure 116: South Asia Neurology Diagnostics Devices Market Forecast & Y-o-Y growth, 2022–2032

Figure 117: South Asia Neurology Diagnostics Devices Market Value Share By Product (2022E)

Figure 118: South Asia Neurology Diagnostics Devices Market Value Share By Application (2022E)

Figure 119: South Asia Neurology Diagnostics Devices Market Value Share By End User (2022E)

Figure 120: South Asia Neurology Diagnostics Devices Market Value Share By Country (2022E)

Figure 121: South Asia Neurology Diagnostics Devices Market Attractiveness Analysis, By Product

Figure 122: South Asia Neurology Diagnostics Devices Market Attractiveness Analysis, By Application

Figure 123: South Asia Neurology Diagnostics Devices Market Attractiveness Analysis, By End User

Figure 124: South Asia Neurology Diagnostics Devices Market Attractiveness Analysis, By Country

Figure 125: India Market Value Proportion Analysis

Figure 126: India Neurology Diagnostics Devices Market Share Analysis (%) By Product, 2021 & 2032

Figure 127: India Neurology Diagnostics Devices Market Share Analysis (%) By Application, 2021 & 2032

Figure 128: India Neurology Diagnostics Devices Market Share Analysis (%) By End User, 2021 & 2032

Figure 129: Malaysia Market Value Proportion Analysis

Figure 130: Malaysia Neurology Diagnostics Devices Market Share Analysis (%) By Product, 2021 & 2032

Figure 131: Malaysia Neurology Diagnostics Devices Market Share Analysis (%) By Application, 2021 & 2032

Figure 132: Malaysia Neurology Diagnostics Devices Market Share Analysis (%) By End User, 2021 & 2032

Figure 133: Indonesia Market Value Proportion Analysis

Figure 134: Indonesia Neurology Diagnostics Devices Market Share Analysis (%) By Product, 2021 & 2032

Figure 135: Indonesia Neurology Diagnostics Devices Market Share Analysis (%) By Application, 2021 & 2032

Figure 136: Indonesia Neurology Diagnostics Devices Market Share Analysis (%) By End User, 2021 & 2032

Figure 137: Thailand Market Value Proportion Analysis

Figure 138: Thailand Neurology Diagnostics Devices Market Share Analysis (%) By Product, 2021 & 2032

Figure 139: Thailand Neurology Diagnostics Devices Market Share Analysis (%) By Application, 2021 & 2032

Figure 140: Thailand Neurology Diagnostics Devices Market Share Analysis (%) By End User, 2021 & 2032

Figure 141: East Asia Neurology Diagnostics Devices Market Volume (Units) Analysis, 2022E & 2032F

Figure 142: East Asia Neurology Diagnostics Devices Market Volume (Units) Analysis, 2022E & 2032F

Figure 143: East Asia Neurology Diagnostics Devices Market Value Analysis, 2012–2021

Figure 144: East Asia Neurology Diagnostics Devices Market Forecast & Y-o-Y growth, 2022–2032

Figure 145: East Asia Neurology Diagnostics Devices Market Value Share By Product (2022E)

Figure 146: East Asia Neurology Diagnostics Devices Market Value Share By Application (2022E)

Figure 147: East Asia Neurology Diagnostics Devices Market Value Share By End User (2022E)

Figure 148: East Asia Neurology Diagnostics Devices Market Value Share By Country (2022E)

Figure 149: East Asia Neurology Diagnostics Devices Market Attractiveness Analysis, By Product

Figure 150: East Asia Neurology Diagnostics Devices Market Attractiveness Analysis, By Application

Figure 151: East Asia Neurology Diagnostics Devices Market Attractiveness Analysis, By End User

Figure 152: East Asia Neurology Diagnostics Devices Market Attractiveness Analysis, By Country

Figure 153: China Market Value Proportion Analysis

Figure 154: China Neurology Diagnostics Devices Market Share Analysis (%) By Product, 2021 & 2032

Figure 155: China Neurology Diagnostics Devices Market Share Analysis (%) By Application, 2021 & 2032

Figure 156: China Neurology Diagnostics Devices Market Share Analysis (%) By End User, 2021 & 2032

Figure 157: Japan Market Value Proportion Analysis

Figure 158: Japan Neurology Diagnostics Devices Market Share Analysis (%) By Product, 2021 & 2032

Figure 159: Japan Neurology Diagnostics Devices Market Share Analysis (%) By Application, 2021 & 2032

Figure 160: Japan Neurology Diagnostics Devices Market Share Analysis (%) By End User, 2021 & 2032

Figure 161: South Korea Market Value Proportion Analysis

Figure 162: South Korea Neurology Diagnostics Devices Market Share Analysis (%) By Product, 2021 & 2032

Figure 163: South Korea Neurology Diagnostics Devices Market Share Analysis (%) By Application, 2021 & 2032

Figure 164: South Korea Neurology Diagnostics Devices Market Share Analysis (%) By End User, 2021 & 2032

Figure 165: Oceania Neurology Diagnostics Devices Market Volume (Units) Analysis, 2022E & 2032F

Figure 166: Oceania Neurology Diagnostics Devices Market Volume (Units) Analysis, 2022E & 2032F

Figure 167: Oceania Neurology Diagnostics Devices Market Value Analysis, 2012–2021

Figure 168: Oceania Neurology Diagnostics Devices Market Forecast & Y-o-Y growth, 2022–2032

Figure 169: Oceania Neurology Diagnostics Devices Market Value Share By Product (2022E)

Figure 170: Oceania Neurology Diagnostics Devices Market Value Share By Application (2022E)

Figure 171: Oceania Neurology Diagnostics Devices Market Value Share By End User (2022E)

Figure 172: Oceania Neurology Diagnostics Devices Market Value Share By Country (2022E)

Figure 173: Oceania Neurology Diagnostics Devices Market Attractiveness Analysis, By Product

Figure 174: Oceania Neurology Diagnostics Devices Market Attractiveness Analysis, By Application

Figure 175: Oceania Neurology Diagnostics Devices Market Attractiveness Analysis, By End User

Figure 176: Oceania Neurology Diagnostics Devices Market Attractiveness Analysis, By Country

Figure 177: Australia Market Value Proportion Analysis

Figure 178: Australia Neurology Diagnostics Devices Market Share Analysis (%) By Product, 2021 & 2032

Figure 179: Australia Neurology Diagnostics Devices Market Share Analysis (%) By Application, 2021 & 2032

Figure 180: Australia Neurology Diagnostics Devices Market Share Analysis (%) By End User, 2021 & 2032

Figure 181: New Zealand Market Value Proportion Analysis

Figure 182: New Zealand Neurology Diagnostics Devices Market Share Analysis (%) By Product, 2021 & 2032

Figure 183: New Zealand Neurology Diagnostics Devices Market Share Analysis (%) By Application, 2021 & 2032

Figure 184: New Zealand Neurology Diagnostics Devices Market Share Analysis (%) By End User, 2021 & 2032

Figure 185: Middle East and Africa Neurology Diagnostics Devices Market Volume (Units) Analysis, 2022E & 2032F

Figure 186: Middle East and Africa Neurology Diagnostics Devices Market Volume (Units) Analysis, 2022E & 2032F

Figure 187: Middle East and Africa Neurology Diagnostics Devices Market Value Analysis, 2012–2021

Figure 188: Middle East and Africa Neurology Diagnostics Devices Market Forecast & Y-o-Y growth, 2022–2032

Figure 189: Middle East and Africa Neurology Diagnostics Devices Market Value Share By Product (2022E)

Figure 190: Middle East and Africa Neurology Diagnostics Devices Market Value Share By Application (2022E)

Figure 191: Middle East and Africa Neurology Diagnostics Devices Market Value Share By End User (2022E)

Figure 192: Middle East and Africa Neurology Diagnostics Devices Market Value Share By Country (2022E)

Figure 193: Middle East and Africa Neurology Diagnostics Devices Market Attractiveness Analysis, By Product

Figure 194: Middle East and Africa Neurology Diagnostics Devices Market Attractiveness Analysis, By Application

Figure 195: Middle East and Africa Neurology Diagnostics Devices Market Attractiveness Analysis, By End User

Figure 196: Middle East and Africa Neurology Diagnostics Devices Market Attractiveness Analysis, By Country

Figure 197: GCC Countries Market Value Proportion Analysis

Figure 198: GCC Countries Neurology Diagnostics Devices Market Share Analysis (%) By Product, 2021 & 2032

Figure 199: GCC Countries Neurology Diagnostics Devices Market Share Analysis (%) By Application, 2021 & 2032

Figure 200: GCC Countries Neurology Diagnostics Devices Market Share Analysis (%) By End User, 2021 & 2032

Figure 201: Turkey Market Value Proportion Analysis

Figure 202: Turkey Neurology Diagnostics Devices Market Share Analysis (%) By Product, 2021 & 2032

Figure 203: Turkey Neurology Diagnostics Devices Market Share Analysis (%) By Application, 2021 & 2032

Figure 204: Turkey Neurology Diagnostics Devices Market Share Analysis (%) By End User, 2021 & 2032

Figure 205: South Africa Market Value Proportion Analysis

Figure 206: South Africa Neurology Diagnostics Devices Market Share Analysis (%) By Product, 2021 & 2032

Figure 207: South Africa Neurology Diagnostics Devices Market Share Analysis (%) By Application, 2021 & 2032

Figure 208: South Africa Neurology Diagnostics Devices Market Share Analysis (%) By End User, 2021 & 2032

Figure 209: North Africa Market Value Proportion Analysis

Figure 210: North Africa Neurology Diagnostics Devices Market Share Analysis (%) By Product, 2021 & 2032

Figure 211: North Africa Neurology Diagnostics Devices Market Share Analysis (%) By Application, 2021 & 2032

Figure 212: North Africa Neurology Diagnostics Devices Market Share Analysis (%) By End User, 2021 & 2032

Know thy Competitors

Competitive landscape highlights only certain players
Complete list available upon request

- FAQs -

How much is the revenue from the neurology diagnostics devices market?

The global neurology diagnostics devices market was worth US$ 8.24 billion in of 2021.

What is the demand outlook for neurology diagnostics devices?

The global market for neurology diagnostics systems is expected to reach US$ 21.1 billion by the end of 2032.

At what CAGR did the market expand over the past 9 years?

Revenue from the sales of neurology diagnostics devices increased at 8% CAGR from 2012 to 2021.

Which 5 countries account for the most demand for neurology diagnostics devices?

The U.S., China, India, Germany, and U.K. are witnessing the highest sales of neurology diagnostics equipment.

What is the market outlook for the U.S.?

The U.S. accounted for 93.4% share of the North American market in 2021.

At what percentage is demand for neurology diagnostics devices expected to register growth in Europe?

The European market is predicted to expand at 10% CAGR over the forecast period.

Who are the leading manufacturers of neurology diagnostics devices?

Top companies in the market are Siemens Medical Solutions USA, Inc., General Electric Company, FUJIFILM Holdings America Corporation, Canon Medical Systems USA, Koninklijke Philips N.V., Masimo, Medtronic plc., and Ricoh USA.

How is the market faring in South Korea and Japan?

The South Korean neurology diagnostics devices market is expected to exhibit 5.9% CAGR, and the Japanese market will surge at a value of 12.6% CAGR.

What growth rate is expected in India for neurology diagnostics devices?

The Indian market is set to expand rapidly at a CAGR of 7.3% through 2032.

Neurology Diagnostics Devices Market

Schedule a Call